Home | | Biotechnology Applying the Genetic Revolution | Delivery of Antisense Therapies

Chapter: Biotechnology Applying the Genetic Revolution: RNA-Based Technologies

Delivery of Antisense Therapies

Getting antisense oligonucleotides into cells requires special techniques, because they do not cross cell membranes easily enough on their own to be effective.

DELIVERY OF ANTISENSE THERAPIES

Getting antisense oligonucleotides into cells requires special techniques, because they do not cross cell membranes easily enough on their own to be effective. Getting the antisense oligonucleotide into the correct cellular location poses another obstacle to devising methods of antisense therapy. Although the uptake of oligonucleotides occurs by an unknown mechanism, the process is active. That is, uptake depends on temperature, the concentration of the oligonucleotide, and the type of cell. It is thought that oligonucleotides are taken up by endocytosis and pinocytosis. (Pinocytosis is similar to endocytosis, but the droplets that enter the cell are much smaller.) There is also a possibility that oligonucleotides enter via a membrane-bound receptor at very low concentrations, whereas at higher concentrations, they enter via pinocytosis and endocytosis.

A common method to deliver oligonucleotides to cells is to encapsulate the oligonucleotides in liposomes (Fig. 5.8A). Liposomes are small vesicles made of bilayers of phospholipids and cholesterol. Whether the liposome is neutral or positively charged depends on the type of phospholipid used to manufacture them. The oligonucleotides ride on the exterior if the liposome is positively charged or are encapsulated inside the aqueous interior. Positively charged liposomes are drawn to the cell surface because it is negatively charged, and the entire





liposome, oligonucleotides and all, is engulfed by endocytosis. Some liposomes contain “helper” molecules that make the endosomal membrane unstable and release the liposome directly into the cytoplasm. Other delivery “vehicles” are cationic polymers, which include poly-L-lysine and polyethyleneimine. These operate via electrostatic interactions as discussed earlier, but they are toxic when taken into the cell; therefore, they are not used very often.

 

When the endosomal pathway is used for uptake, as with liposomes, there is a good chance that the antisense oligonucleotide will be degraded or not released to the cytoplasm. To alleviate this problem, antisense oligonucleotides may be delivered to the cell attached to basic peptides (see Fig. 5.8B). These include the Tat protein of HIV-1, the N-terminal segment of HA2 subunit of influenza virus agglutinin protein, and Antennapedia peptide from Drosophila (which normally acts as a transcription factor). These peptides are able to enter the cell nucleus. By attaching these to oligonucleotides, the antisense oligonucleotides are taken directly into the nucleus.



 

Other methods to get oligonucleotides into the cells require chemically or manually disrupting the membrane (see Fig. 5.8). Membrane pores can be generated by streptolysin O permeabilization (see Fig. 5.8C) or electroporation. Streptolysin O is a toxin from Streptococci bacteria that aggregates after binding to cholesterol in the membrane, forming a pore. The oligonucleotide passes through the pore and enters the cytoplasm directly. Antisense oligonucleotides can also be microinjected directly into each cell, but this method cannot be used for treating patients and is only useful for small-scale experiments on cultured cells (Fig. 5.9). Another mechanical method is called scrape-loading (see Fig. 5.9). Here, adherent cultured cells are gently scraped off the dish while the oligonucleotide bathes the cells. Removal of the cells probably creates small openings that allow the oligonucleotides to enter the cytoplasm.

Antisense oligonucleotides enter the target cell by endocytosis of oligonucleotide-filled liposomes, by rid-ing on basic peptides that normally enter the nucleus, by passing through pores created by streptolysin O, or by mechanical shearing.

Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Biotechnology Applying the Genetic Revolution: RNA-Based Technologies : Delivery of Antisense Therapies |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.